Michael Baria: Is PRP Disease Modifying in Osteoarthritis?
Michael Baria, Lead for The Early Osteoarthritis and Joint Health Program at The Ohio State University Wexner Medical Center, Head Team Physician for Ohio State Wrestling at The Ohio State University Department of Athletics, shared a post on LinkedIn about a recent article by Jiabao Chu et al. published in KSSTA:
“Here is a study I don’t think has gotten nearly enough attention.
Chu et al randomized over 600 knee OA patients (that alone is a feat) to receive either 3, weekly LP-PRP (4 fold platelets) or saline placebo.
Beyond the usual symptom improvement, the imaging results are impressive.
At 5 years, the PRP group lost cartilage volume at half the rate compared to saline.
A single round of PRP reduced cartilage loss for 5 years.
Amazing.
Whereas 10 years ago, the party line was that PRP is still only modifying symptoms, we can put to bed the question ‘is PRP disease modifying?‘.
We have clear evidence it is.
More encouraging; this was disease modifying with only 1 round of treatment.
Most of our patients routinely seek care every 6-12 months so we have every expectation their outcomes are even better.”
Title: Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis
Authors: Jiabao Chu, Weifeng Duan, Ziqiang Yu, Tao Tao, Jie Xu, Qianli Ma, Lingying Zhao, Jiong Jiong Guo
Read the Full Article on KSSTA
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 27, 2026, 07:27Alexander Misono: Chronic Deep Vein Thrombosis and the Impact of Delayed Treatment
-
Sep 27, 2026, 07:17Emma Copperwaite: Back to BBTS With New Research and New Ideas
-
Sep 27, 2026, 05:58Alefiya B.: Imagine Treating a Genetic Disorder by Giving Cells the Instructions They are Missing
-
Sep 27, 2026, 04:5310 Posts Not to Miss This Week
-
Sep 27, 2026, 03:23Massimo Martino: VEN-DEC-GITMO – Advancing AML Treatment in Older Patients
-
Sep 27, 2026, 03:08Arrigo Francesco Giuseppe Cicero: Why Earlier LDL-C Lowering May Matter in Cardiovascular Prevention
-
Sep 27, 2026, 02:51Veronique Witko-Sarsat: Thromboinflammation at the 17th World Congress of Inflammation
-
Sep 27, 2026, 01:45Jin-Xiong She: Functional Iron Deficiency in the Setting of Chronic Inflammation
-
Sep 27, 2026, 01:44Crystal Karakochuk: Scientific Reports Launches New Collection on Iron Deficiency and Anemia